RecruitingNCT05985525
Microvascular Monitoring in Circulatory Shock and Sepsis (MiMICSS)
Microvascular Monitoring in Circulatory Shock and Sepsis (MiMICSS): Prospective Observational Cohort Study
Sponsor
University of Manitoba
Enrollment
100 participants
Start Date
May 27, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
Investigation of the feasibility of using near-infrared spectroscopy (NIRS) to monitor microvascular function in critically ill patients.
Eligibility
Min Age: 18 Years
Inclusion Criteria2
- Admitted to ICU
- Receiving invasive mechanical ventilation
Exclusion Criteria8
- Body Mass Index >40
- More than 24 hours has elapsed since ICU admission
- Death is deemed to be imminent and inevitable during the next 24 hours
- Known allergy to the textile components of the device
- Significant clinical jaundice, ecchymosis
- COVID positive microbiological result
- The treating clinician believes that participation in the domain would not be in the best interests of the patient
- Consent declined from patient or authorized third party
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICESkeletal muscle and cerebral NIRS (research device)
NIRS applied on skeletal muscle and brain on days 1, 3, and 8 of ICU admission. Monitoring applied for up to 24hrs on each day.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05985525
Related Trials
Crystalloid Fluid Choice and Neurological Outcome in Patients After Subarachnoid Haemorrhage
NCT040435983 locations
Stop Sepsis Through Home Monitoring Cooperative
NCT069209791 location
Efficacy and Safety of Cytokine Adsorption and Plasma Exchange in Patients With ACLF and Sepsis
NCT065628031 location
Effect of Protocolized Magnesium Replacement on Mortality and Atrial Fibrillation in Critically Ill Patients
NCT071738556 locations
Aminoglycosides in Early Sepsis
NCT067126415 locations